Vanta Bioscience Limited (VANTABIO.BO)
INR 42.57
(0.0%)
INR 42.57
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 97.22 Million INR | 66.8% |
| 2022 | 58.28 Million INR | -37.95% |
| 2021 | 93.94 Million INR | -4.29% |
| 2020 | 98.15 Million INR | -28.63% |
| 2019 | 137.53 Million INR | 13.85% |
| 2018 | 120.8 Million INR | 211.61% |
| 2017 | 38.76 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 FY | 97.22 Million INR | 66.8% |
| 2023 Q2 | 61.75 Million INR | 78.89% |
| 2023 Q4 | 35.47 Million INR | -42.57% |
| 2022 Q2 | 28.23 Million INR | -34.42% |
| 2022 FY | 58.28 Million INR | -37.95% |
| 2022 Q4 | 34.52 Million INR | 22.27% |
| 2021 FY | 93.94 Million INR | -4.29% |
| 2021 Q4 | 43.05 Million INR | -20.01% |
| 2021 Q2 | 53.82 Million INR | 13.01% |
| 2020 Q2 | 52.75 Million INR | -22.55% |
| 2020 Q4 | 47.62 Million INR | -9.73% |
| 2020 FY | 98.15 Million INR | -28.63% |
| 2019 Q2 | 73.3 Million INR | 0.0% |
| 2019 FY | 137.53 Million INR | 13.85% |
| 2019 Q4 | 68.12 Million INR | -7.07% |
| 2018 FY | 120.8 Million INR | 211.61% |
| 2017 FY | 38.76 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 31.27 Million INR | -210.904% |
| Biocon Limited | 147.55 Billion INR | 99.934% |
| Blue Jet Healthcare Limited | 7.11 Billion INR | 98.634% |
| Concord Biotech Limited | 10.16 Billion INR | 99.044% |
| Dishman Carbogen Amcis Limited | 26.15 Billion INR | 99.628% |
| FERMENTA BIOTECH LIMITED | 3.35 Billion INR | 97.103% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -5789.989% |
| Lyka Labs Limited | 1.05 Billion INR | 90.752% |
| Panacea Biotec Limited | 5.51 Billion INR | 98.238% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 3.05 Billion INR | 96.822% |
| Supriya Lifescience Limited | 5.7 Billion INR | 98.295% |
| Syngene International Limited | 34.88 Billion INR | 99.721% |
| TAKE Solutions Limited | 656.08 Million INR | 85.18% |
| Titan Biotech Limited | 1.64 Billion INR | 94.074% |
| Transgene Biotek Limited | 2.34 Million INR | -4039.166% |